3D Printed Occluder Device Can Lower Risk of Stroke-Causing Blood Clots for Patients with Atrial Fibrillation
As we know, 3D printing technology is often used to build personalized, patient-specific medical devices, models, and implants. In his paper, King mentions another report, which is centered on the efforts of a group of researchers with the Dalio Institute of Cardiovascular Imaging at New York–Presbyterian Hospital and Weill Cornell Medicine who are working to develop 3D printed, personalized soft LAA occluding devices that are customized to a specific patient’s anatomy.
Together, the researchers – Sanlin S. Robinson, Seyedhamidreza Alaie, Hannah Sidoti, Jordyn Auge, Lohendran Baskaran, Kenneth Avilés-Fernández, Samantha D. Hollenberg, Robert F. Shepherd, James K. Min, Simon Dunham, and Bobak Mosadegh – used their combined expertise in the areas of biomedical engineering, cardiology, manufacturing, and materials to develop a soft, 3D printed, patient-specific occluder, then published a paper about their efforts in Nature Biomedical Engineering.
Robinson wrote. “This decision occurred while our engineering team was attending the 4th International Symposium on the Left Atrial Appendage in NYC—a clear example of how attending conferences in fields outside of engineering can often stimulate new thoughts on how to execute interdisciplinary research.”“While our ultimate goal is to make an occluder that can be delivered to the left atrial appendage (LAA) percutaneously, in this paper we focused on a clinically relevant surgical approach that allowed us to test the efficacy of the patient-specific design without the added complications of catheter delivery and deployment,”
LAA occluder devices inserted through a catheter look like circular, mini umbrellas, and self-expand inside the LAA in order to prevent blood from flowing into the appendage. While they come in multiple sizes to fit more people, the devices do have some issues, such as the metal hooks used to anchor the device perforating the thin tissue.
The team used CT images of a person’s heart and a CAD program to isolate the surface of the LAA with a 0.5 mm thick shell, adding a valve for inflation and mechanical stabilization to the design. As with many objects we hear about, the occluder itself wasn’t 3D printed, but the molds to create it were: the researchers 3D printed high-resolution molds of the design for casting, filling them with a soft silicone polymer blend so the resulting hollow occluder would conform to the walls of the appendage once it was implanted.
The abstract for the paper reads, “3D printing has been used to create a wide variety of anatomical models and tools for procedural planning and training. Yet, the printing of permanent, soft endocardial implants remains challenging because of the need for haemocompatibility and durability of the printed materials. Here, we describe an approach for the rapid prototyping of patient-specific cardiovascular occluders via 3D printing and static moulding of inflatable silicone/polyurethane balloons derived from volume-rendered computed tomography scans. We demonstrate the use of the approach, which provides custom-made implants made of high-quality, durable and haemocompatible elastomeric materials, in the fabrication of devices for occlusion of the left atrial appendage—a structure known to be highly variable in geometry and the primary source of stroke for patients with atrial fibrillation. We describe the design workflow, fabrication and deployment of patient-specific left atrial appendage occluders and, as a proof-of-concept, show their efficacy using 3D-printed anatomical models, in vitro flow loops and an in vivo large animal model.”
“To demonstrate the feasibility of this workflow, as well as the functionality and performance of the occluder, we implanted our device into a large animal model 2 weeks after receiving the animal’s CT scan,” Robinson explained.
Once the 3D printed occluder was implanted, the researchers filled it with liquid epoxy until it expanded and filled up the space; it then hardened after 24 hours to secure the occluder, which will stop the blood from flowing into the LAA and negating the risk of blood clot formation inside.
Robinson said, “While we did not perform a chronic study, we expect after 30-45 days the atrial facing wall of the occluder to become covered with endothelial and smooth muscle cells, essentially sealing the appendage from the rest of the left atrium.”
While more experiments will be necessary to validate the 3D printed occluder’s long-term performance, Robinson believes that it was a significant first step in 3D printed patient-specific endovascular devices.
Discuss this and other 3D printing topics at 3DPrintBoard.com or share your thoughts in the Facebook comments below.
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and recieve information and offers from thrid party vendors.
You May Also Like
Swiss EMS Group Picks 3D Systems for New Nylon 3D Printing Material
3D Systems (NYSE:DDD) has announced a partnership with EMS-GRILTECH (SIX:EMSN) to develop new 3D printing materials. Leveraging the polyamide manufacturing expertise of EMG-GRILTECH, a business unit of Swiss chemical company...
3D Printing Webinar and Event Roundup: June 26, 2022
Events for this week have already started, like the ISTE Live conference for technology in education down in New Orleans. Stratasys continues its Experience Tour in Ohio, Divide by Zero...
3D Printing News Briefs, June 23, 2022: New Software, DfAM Course, & More
In today’s 3D Printing News Briefs, Lithoz is introducing a new technology and printer, and Artec 3D has launched an update to its Studio software. Finally, on to partnerships, as...
Raytheon Company Behind Next-Gen Spacesuits Opens New 3D Printing Center
Collins Aerospace, a division of Raytheon Technologies, revealed its new additive manufacturing center and the expansion of its maintenance, repair, and overhaul (MRO) capabilities at its Monroe, North Carolina campus....